The US Dept of Defense awarded contracts for COVID-19 disposable isolation gowns
On Sept. 14, 2020, the U.S. Department of Defense (DOD), on behalf of the Department of Health and…
-
-
Valneva announced COVID-19 vaccine partnership with UK Government
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
-
Vaxart announced FDA clearance of IND application for oral COVID-19 vaccine
On Sept. 14, 2020, Vaxart announced that the U.S. Food and Drug Administration (FDA) has completed its review…
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
On Sept. 12 2020, Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK…
-
Transmission of COVID-19 outbreaks associated with child care facilities in Utah
On Sept. 11, 2020, the U.S. Centers for Disease Control and Prevention (CDC) reported that twelve children acquired…
-
MediciNova announced intranasal RS virus vaccine vuccessfully induced neutralizing antibodies against RS virus in mice
On Sept. 11, 2020, MediciNova announced that BioComo, co-developer of MediciNova’s SARS-CoV-2 vaccine for COVID-19, announced that its…
-
Todos Medical announced commercial launch of COVID-19 qPCR test kits in the U.S.
On Sept. 11, 2020, Todos Medical announced that the U.S. Food and Drug Administration (FDA) has added the…
-
NIH ACTIV initiative launched adaptive clinical trials of blood-clotting treatments for COVID-19
On Sept. 10, 2020, the National Institutes of Health launched two of three adaptive Phase 3 clinical trials…
-
Corvus Pharmaceuticals provided update on clinical trial of CPI-006 for patients with COVID-19
On Sept. 10, 2020, Corvus Pharmaceuticals announced updated data from its ongoing Phase 1 study investigating the potential…
-
Head-to-head study demonstrated equivalency and accuracy of COVID-19 rapid point-of-care tests, despite test sensitivity claims
On Sept. 9, 2020, BD (Becton, Dickinson) announced the results of a new research study that demonstrated performance…
-
Pfizer and BioNTech announced data from preclinical studies of mRNA-based vaccine candidate against COVID-19
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
-
COVID-19 | FDA | HIV | Infectious Disease | Vaccine
Pfizer and BioNTech to potentially supply EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2
On Sept. 9, 2020, Pfizer and BioNTech announced that they had concluded exploratory talks with the European Commission…
-
iBio advanced COVID-19 LicKM-subunit vaccine candidate, IBIO-201
On Sept. 9, 2020, iBio announced that it had selected IBIO-201, its LicKM-ubunit vaccine, as its leading candidate…
-
Biology | Biotechnology | COVID-19 | Diagnostics | Disease | Infectious Disease | Oncology | Therapeutics
NanoString announced new GeoMx COVID-19 Consortium, part of the GeoMx Translational Leadership Network
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
-
U.S. COVID-19 cases may be substantially underestimated
On Sept. 9, 2020, UC Berkeley School of Public Health researchers reported that probability analysis showed the U.S….
-
Merck announced positive topline results from phase 3 adult studies evaluating investigational 15-valent pneumococcal conjugate vaccine
On Sept. 9, 2020, Merck announced that two Phase 3 studies evaluating the safety, tolerability and immunogenicity of…
-
AstraZeneca Oxford SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary paused
On Sept. 9, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
-
US Government stopped COVID-19 entry strategy for international air passengers
On Sept. 9, 2020, the U.S. government (USG) announced that it will remove requirements for directing all flights…
-
The ACIP updated flu vaccine recommendations for 2020-2021
On Sept. 9, 2020, the American Academy of Family Physicians (AAFP) reviewed and agreed with the Advisory Committee…
-
Valneva announced IXIARO supply contract with the U.S. Government worth up to $166 million
On Sept. 9, 2020, Valneva announced the signing of a new contract, lasting up to three years, with…
-
Elevated levels of a blood clotting factor linked to worse outcomes in severe COVID-19
On Sept. 9, 2020, Harvard Medical School investigators at Massachusetts General Hospital reported that patients hospitalized with severe…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Measles | Plague | Polio | Therapeutics | Vaccine
Biopharma leaders united to stand with science
On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
-
Biotechnology | COVID-19 | Infectious Disease | Life Science History | Medicine | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency and the Chan Zuckerberg Initiative partnered to create COVID-19 database
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
-
Vaxart’s oral COVID-19 vaccine candidate induced potent systemic and mucosal immune responses in preclinical studies
On Sept. 8, 2020, Vaxart announced pre-publication of a manuscript titled “Preclinical studies of a recombinant adenoviral mucosal…
-
LabCorp launched first combined test for Covid-19, flu and RSV in time for flu season
On Sept. 8, 2020, LabCorp announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
-
INOVIO added Thermo Fisher Scientific to global manufacturing consortium
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
-
DiaSorin Molecular received FDA clearance for the Simplexa Flu A/B & RSV Direct Gen II Assay
On Sept. 7, 2020, DiaSorin Molecular announced that it had received U.S. Food and Drug Administration (FDA) Clearance…
-
Persistent immune memory of COVID-19 found in recovered patient T cells
On Sept. 4, 2020, the University of Oxford researchers found that natural infection with COVID-19 produces a robust…
-
OraSure’s ORAcollect-RNA device Included in EUA granted to MiraDx for SARS-CoV-2 test
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ﾷRNA (OR-100) collection device was included along with other…
-
Roche received FDA Emergency Use Authorization for the cobas SARS-CoV-2 & influenza A/B test for use on cobas 6800/8800 systems
On Sept. 3, 2020, Roche announced that the cobas SARS-CoV-2 & Influenza A/B Test for use on the…
